Skip to main navigation Skip to search Skip to main content

Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions

  • Ron N. Apte*
  • , Yakov Krelin
  • , Xiaoping Song
  • , Shahar Dotan
  • , Eli Recih
  • , Moshe Elkabets
  • , Yaron Carmi
  • , Tatyana Dvorkin
  • , Roslayn M. White
  • , Lubov Gayvoronsky
  • , Shraga Segal
  • , Elena Voronov
  • *Corresponding author for this work
  • Ben-Gurion University of the Negev

Research output: Contribution to journal › Article › peer-review

186 Scopus citations

Abstract

Interleukin-1 (IL-1) comprises a family of closely related genes; the two major agonistic proteins, IL-1α and IL-1β, are pleiotropic and affect mainly inflammation, immunity and haemopoiesis. IL-1β is active solely in its secreted form, whereas IL-1α is active mainly as an intracellular precursor. IL-1 is abundant at tumour sites, where it may affect the process of carcinogenesis, tumour growth and invasiveness and the patterns of tumour-host interactions. Here, we review the effects of micro-environment- and tumour cell-derived IL-1 on malignant processes in experimental tumour models. We propose that membrane-associated IL-1α expressed on malignant cells stimulates anti-tumour immunity, while secretable IL-1β derived from the micro-environment or the malignant cells, activates inflammation that promotes invasiveness and induces tumour-mediated suppression. Inhibition of the function of IL-1 by the inhibitor of IL-1, interleukin-1 receptor antagonist (IL-1Ra), reduces tumour invasiveness and alleviates tumour-mediated suppression, pointing to its feasible use in cancer therapy. Differential manipulation of IL-1α and IL-1β in malignant cells or in the tumour's micro-environment may open new possibilities for using IL-1 in cancer immunotherapy.

Original languageEnglish
Pages (from-to)751-759
Number of pages9
JournalEuropean Journal of Cancer
Volume42
Issue number6
DOIs
StatePublished - Apr 2006
Externally publishedYes

Funding

Funders
German–Israeli DIP
Israel Ministry of Science
United States-Israel Bi-national Foundation
Concern Foundation
Maryland Ornithological Society
German Cancer Research Center
Association for International Cancer Research
United States-Israel Binational Science Foundation
Israel Academy of Sciences and Humanities
Israel Cancer Association
Israel Science Foundation
Office of the Chief Scientist, Ministry of Health

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Anti-tumour immunity
    • Carcinogenesis
    • IL-1α
    • IL-1β
    • Immunogenicity
    • Tumour invasiveness
    • Tumour-host interactions

    Fingerprint

    Dive into the research topics of 'Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions'. Together they form a unique fingerprint.

    Cite this